ESC 365 - Orthostatic blood pressure changes and incident atrial fibrillation in patients with hypertension: Insights from the SPRINT trial

ESC Professional Premium Access

Orthostatic blood pressure changes and incident atrial fibrillation in patients with hypertension: Insights from the SPRINT trial

Session: Hypertension target organ damage

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor J. Wang (Beijing, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Jue Wang

Beijing (China)

0 follower

8 more presentations in this session

Diagnostic and prognostic value of ECG-predicted hypertension mediated left ventricular hypertrophy using machine learning

Speaker: Doctor H. Naderi (London, GB)

Carotid-Femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes

Speaker: Doctor A. Maloberti (Milan, IT)

Cardiac magnetic resonance (CMR) height-based allometric scaling in Southeast Asians; implications in the diagnosis and prognosis of left ventricular hypertrophy (LVH): the REMODEL study

Speaker: Mr C. Lee (Dundee, GB)

Relationship between renin, aldosterone, aldosterone-to-renin ratio and left ventricular mass index in young adults

Speaker: Doctor R. Ananda (Melbourne, AU)

Impact of changes in left heart geometry on predicting new-onset atrial fibrillation in patients with hypertension

Speaker: Assistant Professor H. KIM (Seoul, KR)

Access the full session

Hypertension target organ damage

Speakers: Doctor J. Wang, Doctor H. Naderi, Doctor A. Maloberti, Mr C. Lee, Doctor R. Ananda...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources